Geographic Variations in Diagnosis and Treatment of Ankylosing Spondylitis in the United States: A Real-World Study.

Deodhar, Atul; Kruzikas, Denise; Zhou, Lili; Biljan, Ana; Saffore, Christopher D

Deodhar, Atul; Kruzikas, Denise; Zhou, Lili; Biljan, Ana; Saffore, Christopher D.

Afiliação

Deodhar A; Department of Medicine, Rheumatology Clinics, Oregon Health and Science University, Portland, OR, USA. deodhara@ohsu.edu.
Kruzikas D; AbbVie Inc., North Chicago, IL, USA.
Zhou L; AbbVie Inc., North Chicago, IL, USA.
Biljan A; AbbVie Inc., North Chicago, IL, USA.
Saffore CD; AbbVie Inc., North Chicago, IL, USA.

Rheumatol Ther ; 9(2): 447-463, 2022 Apr.

Article em En | MEDLINE | ID: mdl-34927217

Palavras-chave

Ankylosing spondylitis; Biologic disease-modifying antirheumatic drugs; Conventional synthetic disease-modifying antirheumatic drugs; Diagnosis; Epidemiology; Opioids; Real world; States; Targeted immunomodulator; United States

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies Idioma: En Revista: Rheumatol Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google